Literature DB >> 7862882

An analysis of response to nicotine infusion using an automated radiotelemetry system.

S F Robinson1, J R Pauly, M J Marks, A C Collins.   

Abstract

Previous studies from our laboratory have demonstrated that chronic nicotine infusion evokes tolerance to nicotine injected IP several hours after withdrawal from chronic infusion. This method may introduce problems related to withdrawal reactions and to stress associated with handling of the animals. The studies reported here measured tolerance to nicotine in mice using an automated radiotelemetry system. DBA/2 mice were infused intravenously with saline for 4 days followed by infusion of a 4 mg/kg per h dose of nicotine for 7 days. After the nicotine treatment, the mice were infused with saline for 7 days. The nicotine was infused continuously or in four 1 mg/kg pulses, two 2 mg/kg pulses or one 4 mg/kg pulse each hour. Home cage activity and body temperature were measured throughout the treatment periods using a radiotelemetry system. Nicotine infusion produced an abrupt decrease in body temperature and activity, but this effect was totally reversed within 12 h in the continuously infused and four infusions/h treatment groups. Mice that received one or two infusions/h also showed a rapid response to nicotine that was reversed as treatment proceeded, but nicotine continued to produce a measurable effect for several days. After nicotine withdrawal, temperature and activity returned to predrug infusion values in all of the groups except those infused once per hour. This group showed depressed activity for a minimum of 3 days after nicotine treatment stopped. Thus, the kinetics of nicotine administration affected the intensity of response during continued treatment as well as activity after cessation of chronic treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7862882     DOI: 10.1007/bf02244760

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  34 in total

1.  Effect of nicotine pretreatment on nicotine-induced seizures.

Authors:  L L Miner; A C Collins
Journal:  Pharmacol Biochem Behav       Date:  1988-02       Impact factor: 3.533

2.  MK801 attenuates behavioural adaptation to chronic nicotine administration in rats.

Authors:  M Shoaib; I P Stolerman
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

3.  Influences of genotype and sex on behavioral tolerance to nicotine in mice.

Authors:  P C Hatchell; A C Collins
Journal:  Pharmacol Biochem Behav       Date:  1977-01       Impact factor: 3.533

4.  Effects of nicotine administration and its withdrawal on plasma corticosterone and brain 5-hydroxyindoles.

Authors:  M E Benwell; D J Balfour
Journal:  Psychopharmacology (Berl)       Date:  1979-05-08       Impact factor: 4.530

5.  Conditioned tolerance to the anorectic and corticosterone-elevating effects of nicotine.

Authors:  A R Caggiula; L H Epstein; S M Antelman; S S Saylor; K A Perkins; S Knopf; R Stiller
Journal:  Pharmacol Biochem Behav       Date:  1991-09       Impact factor: 3.533

6.  Dopamine-like action of nicotine: lack of tolerance and reverse tolerance.

Authors:  E P Lapin; H S Maker; H Sershen; Y Hurd; A Lajtha
Journal:  Brain Res       Date:  1987-03-31       Impact factor: 3.252

7.  The effects of nicotine on locomotor activity in non-tolerant and tolerant rats.

Authors:  P B Clarke; R Kumar
Journal:  Br J Pharmacol       Date:  1983-02       Impact factor: 8.739

8.  Exposure to nicotine enhances the behavioral stimulant effect of nicotine and increases binding of [3H]acetylcholine to nicotinic receptors.

Authors:  C Ksir; R Hakan; D P Hall; K J Kellar
Journal:  Neuropharmacology       Date:  1985-06       Impact factor: 5.250

9.  Desensitization of nicotine-stimulated [3H]dopamine release from mouse striatal synaptosomes.

Authors:  S R Grady; M J Marks; A C Collins
Journal:  J Neurochem       Date:  1994-04       Impact factor: 5.372

10.  Time course study of the effects of chronic nicotine infusion on drug response and brain receptors.

Authors:  M J Marks; J A Stitzel; A C Collins
Journal:  J Pharmacol Exp Ther       Date:  1985-12       Impact factor: 4.030

View more
  1 in total

1.  Activation of PPARγ Attenuates the Expression of Physical and Affective Nicotine Withdrawal Symptoms through Mechanisms Involving Amygdala and Hippocampus Neurotransmission.

Authors:  Esi Domi; Francesca Felicia Caputi; Patrizia Romualdi; Ana Domi; Giulia Scuppa; Sanzio Candeletti; Alison Atkins; Markus Heilig; Gregory Demopulos; George Gaitanaris; Roberto Ciccocioppo; Massimo Ubaldi
Journal:  J Neurosci       Date:  2019-11-04       Impact factor: 6.167

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.